FOLLICULAR LYMPHOMA ( FL)

This is the first study in people testing a new drug called LTZ-301 for adults with non-Hodgkin lymphoma that has come back or stopped responding to at least two prior treatments. The main goals are to find a safe dose and see how the body handles the drug, while also checking fo…

This is an early-stage study testing the safety and best dose of a new CAR-T cell therapy called GF-CART01. It is for adults aged 18-70 with certain B-cell blood cancers that have come back or not responded to at least two prior treatments. The main goal is to find a safe dose an…

This study is testing a two-part treatment for B-cell lymphoma that has come back or not responded to other therapies. First, doctors modify a patient's own immune cells (CAR-T cells) to attack the cancer. Then, they add an immunotherapy drug (sintilimab) for up to a year to help…

This early-stage study is testing an experimental drug called MDX2003 for people with several types of B-cell lymphoma that have come back or stopped responding to at least two prior treatments. The main goals are to find a safe dose and see if the drug can shrink tumors. It will…

This study is testing whether an experimental drug called odronextamab works better than the current standard treatment for people newly diagnosed with follicular lymphoma, a type of blood cancer. About 822 participants will be randomly assigned to receive either the new drug or …

This is a first-in-human study testing a new oral drug called NX-5948 in adults with advanced B-cell blood cancers that have returned or stopped responding to standard treatments. The main goals are to find a safe dose and see if the drug can shrink tumors. The study will enroll …

This study is testing an experimental drug called surovatamig for adults whose B-cell non-Hodgkin lymphoma has come back or stopped responding to at least two prior treatments. The main goals are to see if the drug can shrink the cancer and how safe it is for patients. Researcher…

This large, late-stage trial is testing whether adding a new drug, epcoritamab, to a standard treatment (rituximab and lenalidomide) works better and is safer than standard chemotherapy for adults newly diagnosed with follicular lymphoma. Follicular lymphoma is a common, slow-gro…

This study is testing a new oral medicine called mevrometostat, alone and combined with an existing drug (enzalutamide), for men with advanced prostate cancer that has worsened despite prior treatment. The main goals are to find a safe dose and see if the treatment can help contr…

This study aims to discover molecular patterns in the blood and tissue of patients with acute myeloid leukemia (AML) or follicular lymphoma. Researchers will collect samples during patients' routine care to understand how these patterns relate to treatment outcomes and disease pr…

This study is creating a national registry to track how nearly 3000 people in Germany with various blood cancers are treated in real-world settings. It will document what treatments patients receive, how they respond, and how their quality of life is affected over time. The goal …